Apyx Medical Corp reports results for the quarter ended December 31 - Earnings Summary

• Apyx Medical Corp APYX.OQ reported a quarterly adjusted loss of 12 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -28 cents. The mean expectation of four analysts for the quarter was for a loss of 16 cents per share. Wall Street expected results to range from -18 cents to -13 cents per share.

• Revenue fell 3% to $14.22 million from a year ago; analysts expected $13.39 million.

• Apyx Medical Corp's reported EPS for the quarter was a loss of 12 cents​.

• The company reported a quarterly loss of $4.63 million.

• Apyx Medical Corp shares had fallen by 32.3% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 1.5% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "hold"

Wall Street's median 12-month price target for Apyx Medical Corp is $3.00

This summary was machine generated from LSEG data March 13 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)